Form 4: Monogram CTO Shamaei Acquires 250,000 Stock Options

Monogram Technologies' Chief Technology Officer, Kamran Shamaei, acquired 250,000 stock options with an exercise price of $2.50, effective January 8, 2025.

Summary

• Kamran Shamaei, Chief Technology Officer of Monogram Technologies Inc. (MGRM), acquired 250,000 stock options.
• The transaction date for the option grant is January 8, 2025.
• The exercise price for these stock options is $2.50 per share.
• The options become exercisable on January 8, 2032, and have an expiration date of January 8, 2035.
• The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
• Following this transaction, Kamran Shamaei beneficially owns 250,000 derivative securities (stock options).
• The company uses the Black-Scholes-Merton option-pricing model to determine the fair value of stock awards.

Sentiment

Score: 6

Explanation: Slightly positive. The grant of stock options to a key executive aligns their interests with shareholders and is a standard practice for incentivizing long-term performance. The use of a 10b5-1 plan adds transparency. However, it's a routine compensation event and doesn't indicate a significant new development.

Positives

• The grant of stock options aligns the Chief Technology Officer's interests with those of shareholders, incentivizing long-term company performance.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-planned, non-discretionary transaction, which enhances transparency and reduces concerns about opportunistic insider trading.

Negatives

• The value of the options is contingent on the future appreciation of Monogram Technologies' stock price above the $2.50 exercise price, offering no immediate cash benefit to the executive.
• The options do not become exercisable until January 8, 2032, representing a long vesting period before the executive can realize any gains.

Risks

• The fair value of stock awards, determined using the Black-Scholes-Merton option-pricing model, relies on highly subjective and complex assumptions, including the estimated fair value and price volatility of the company's common stock and the expected term of the option.

Future Outlook

The grant of long-term stock options suggests an expectation of future growth and increased shareholder value, as the options' profitability is tied to the company's stock price appreciation over the next decade.

Management Comments

• The Company uses the Black-Scholes-Merton ('Black-Scholes') option-pricing model to determine the fair value of stock awards. The Black-Scholes option-pricing model requires the use of highly subjective and complex assumptions, including the estimated fair value and price volatility of the Company's common stock and the expected term of the option.

Industry Context

Stock option grants are a common form of executive compensation in the technology sector and publicly traded companies, designed to attract, retain, and motivate key personnel by linking their financial incentives to the company's long-term performance and shareholder returns.

Comparison to Industry Standards

• The use of stock options as a compensation tool for a Chief Technology Officer is standard practice across the technology industry, comparable to grants seen at companies like Google, Apple, or smaller tech firms, aiming to align executive incentives with long-term shareholder value.
• The structure, including an exercise price and a multi-year vesting/expiration schedule, is typical for executive equity awards, reflecting a commitment to future performance rather than immediate reward.

Stakeholder Impact

• Shareholders: The grant of stock options to the CTO aims to align management's financial interests with shareholder value creation, potentially leading to improved long-term performance.
• Employees: The compensation structure for a key executive may influence morale and retention strategies for other high-level employees.

Next Steps

• Kamran Shamaei will hold the 250,000 stock options until they become exercisable on January 8, 2032.
• The options can be exercised at any time between January 8, 2032, and their expiration date of January 8, 2035, assuming the stock price is above the exercise price of $2.50.

Key Dates

Recommendation

This Form 4 reports a routine grant of stock options to a key executive as part of their compensation package. While it indicates alignment of interests, it does not present new fundamental information or a significant change in the company's outlook that would warrant a change in investment recommendation. Investors should 'hold' and continue to monitor the company's operational and financial performance.

Keywords

Monogram Technologies, MGRM, Kamran Shamaei, Chief Technology Officer, Stock Options, Insider Transaction, SEC Form 4, Executive Compensation, Rule 10b5-1, Derivative Securities